Yasushi Kanazawa

785 total citations
21 papers, 684 citations indexed

About

Yasushi Kanazawa is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Yasushi Kanazawa has authored 21 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Epidemiology. Recurrent topics in Yasushi Kanazawa's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Yasushi Kanazawa is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Yasushi Kanazawa collaborates with scholars based in Japan. Yasushi Kanazawa's co-authors include Kazunori Utsunomiya, Tamotsu Yokota, Keiichiro Matoba, Daiji Kawanami, Sho Ishizawa, Naoko Tajima, Hideaki Kurata, Yosuke Nagai, Kanta Taniguchi and Yusuke Takeda and has published in prestigious journals such as PLoS ONE, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Yasushi Kanazawa

20 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Kanazawa Japan 15 297 234 113 94 86 21 684
Sho Ishizawa Japan 13 228 0.8× 155 0.7× 77 0.7× 78 0.8× 54 0.6× 19 532
Can Wu China 13 333 1.1× 172 0.7× 89 0.8× 53 0.6× 65 0.8× 15 710
Andrea Hodgkinson United Kingdom 15 264 0.9× 85 0.4× 121 1.1× 89 0.9× 91 1.1× 28 702
Éva Dizin Switzerland 15 446 1.5× 150 0.6× 61 0.5× 71 0.8× 87 1.0× 19 768
Regine Schroeder Germany 16 414 1.4× 260 1.1× 119 1.1× 81 0.9× 138 1.6× 21 912
Yoshiki Higashijima Japan 14 362 1.2× 164 0.7× 198 1.8× 50 0.5× 48 0.6× 24 729
Leighton R. James United States 19 472 1.6× 133 0.6× 166 1.5× 101 1.1× 130 1.5× 38 961
Gabriella Casalena United States 14 611 2.1× 305 1.3× 48 0.4× 109 1.2× 121 1.4× 18 1.1k
Yu Ishimoto Japan 10 346 1.2× 274 1.2× 42 0.4× 59 0.6× 85 1.0× 21 880

Countries citing papers authored by Yasushi Kanazawa

Since Specialization
Citations

This map shows the geographic impact of Yasushi Kanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Kanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Kanazawa more than expected).

Fields of papers citing papers by Yasushi Kanazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Kanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Kanazawa. The network helps show where Yasushi Kanazawa may publish in the future.

Co-authorship network of co-authors of Yasushi Kanazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Kanazawa. A scholar is included among the top collaborators of Yasushi Kanazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Kanazawa. Yasushi Kanazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2022). ROCK2-induced metabolic rewiring in diabetic podocytopathy. Communications Biology. 5(1). 341–341. 11 indexed citations
3.
Nagai, Yosuke, Keiichiro Matoba, Yusuke Takeda, et al.. (2022). Rho-associated, coiled-coil–containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism. Kidney International. 102(3). 536–545. 16 indexed citations
4.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2020). ROCK Inhibition May Stop Diabetic Kidney Disease. JMA Journal. 3(3). 154–163. 12 indexed citations
5.
Takeda, Yusuke, Keiichiro Matoba, Daiji Kawanami, et al.. (2019). ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. International Journal of Molecular Sciences. 20(6). 1331–1331. 48 indexed citations
6.
Nagai, Yosuke, Daiji Kawanami, Keiichiro Matoba, et al.. (2018). Rho-Kinase Induces CTGF Expression through Actin Dynamics in Mesangial Cells. Diabetes. 67(Supplement_1). 1 indexed citations
7.
Hayashi, Takeshi, Azusa Yamato, Yasushi Kanazawa, et al.. (2018). Acth-Dependent Cushing Syndrome Caused by Thymic Carcinoid Diagnosed After Delivery of a Healthy Child. AACE Clinical Case Reports. 4(6). e476–e481. 1 indexed citations
8.
Matoba, Keiichiro, Daiji Kawanami, Yosuke Nagai, et al.. (2017). Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy. International Journal of Molecular Sciences. 18(8). 1795–1795. 38 indexed citations
9.
Niimi, Naoko, et al.. (2015). Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA. Histochemistry and Cell Biology. 144(3). 249–259. 27 indexed citations
10.
Matoba, Keiichiro, Daiji Kawanami, Jun Kinoshita, et al.. (2014). Rho-kinase regulation of TNF-α-induced nuclear translocation of NF-κB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells. American Journal of Physiology-Renal Physiology. 307(5). F571–F580. 42 indexed citations
11.
Ishizawa, Sho, Junko Takahashi‐Fujigasaki, Yasushi Kanazawa, et al.. (2014). Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clinical and Experimental Nephrology. 18(6). 844–852. 34 indexed citations
12.
Kawanami, Daiji, Keiichiro Matoba, Rina Okada, et al.. (2013). Fasudil inhibits ER stress-induced VCAM-1 expression by modulating unfolded protein response in endothelial cells. Biochemical and Biophysical Research Communications. 435(2). 171–175. 14 indexed citations
13.
Kanazawa, Yasushi, Junko Takahashi‐Fujigasaki, Sho Ishizawa, et al.. (2013). The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells. Experimental Neurology. 247. 438–446. 21 indexed citations
14.
Matoba, Keiichiro, Daiji Kawanami, Rina Okada, et al.. (2013). Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney International. 84(3). 545–554. 80 indexed citations
15.
Yokoyama, Keitaro, Akio Nakashima, Mitsuyoshi Urashima, et al.. (2012). Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes. PLoS ONE. 7(12). e51171–e51171. 19 indexed citations
16.
Kawanami, Daiji, Keiichiro Matoba, Yasushi Kanazawa, et al.. (2011). Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells. Biochemical and Biophysical Research Communications. 411(4). 798–803. 48 indexed citations
17.
Matoba, Keiichiro, Daiji Kawanami, Sho Ishizawa, et al.. (2010). Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochemical and Biophysical Research Communications. 402(4). 725–730. 72 indexed citations
18.
Utsunomiya, Kazunori, Sho Ishizawa, Yasushi Kanazawa, et al.. (2009). Association of Polymorphism of Estrogen Receptor-.ALPHA. Gene with Circulating Levels of Adiponectin in Postmenopausal Women with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 16(3). 250–255. 15 indexed citations
19.
Utsunomiya, Kazunori, Sho Ishizawa, Yasushi Kanazawa, et al.. (2009). Association of Urinary Albumin Excretion with Insulin Resistance in Japanese Subjects: Impact of Gender Difference on Insulin Resistance. Internal Medicine. 48(18). 1621–1627. 8 indexed citations
20.
Utsunomiya, Kazunori, Kanta Taniguchi, Tamotsu Yokota, et al.. (2007). The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 568(1-3). 242–247. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sho Ishizawa Breakdown of academic impact, for papers by Can Wu Breakdown of academic impact, for papers by Andrea Hodgkinson Breakdown of academic impact, for papers by Éva Dizin Breakdown of academic impact, for papers by Regine Schroeder Breakdown of academic impact, for papers by Yoshiki Higashijima Breakdown of academic impact, for papers by Leighton R. James Breakdown of academic impact, for papers by Gabriella Casalena Breakdown of academic impact, for papers by Yu Ishimoto
Rankless by CCL
2026